Urinary selective serotonin reuptake inhibitors across critical windows of pregnancy establishment: a prospective cohort study of fecundability and pregnancy loss.

[1]  M. Menke,et al.  Selective Serotonin Reuptake Inhibitors and Fertility: Considerations for Couples Trying to Conceive , 2019, Harvard review of psychiatry.

[2]  C. Coutifaris,et al.  Major depression, antidepressant use, and male and female fertility. , 2018, Fertility and sterility.

[3]  A. Butwick,et al.  Prevalence of Depression Among Women of Reproductive Age in the United States. , 2018, Obstetrics and gynecology.

[4]  Q. Gu,et al.  Antidepressant Use Among Persons Aged 12 and Over:United States,2011-2014. , 2017, NCHS data brief.

[5]  K. Rothman,et al.  Depression, anxiety, and psychotropic medication use and fecundability. , 2016, American journal of obstetrics and gynecology.

[6]  Marianne M. Casilla-Lennon,et al.  The effect of antidepressants on fertility. , 2016, American journal of obstetrics and gynecology.

[7]  Nisha D Almeida,et al.  Risk of Miscarriage in Women Receiving Antidepressants in Early Pregnancy, Correcting for Induced Abortions , 2016, Epidemiology.

[8]  Enrique F Schisterman,et al.  Expanded findings from a randomized controlled trial of preconception low-dose aspirin and pregnancy loss. , 2016, Human reproduction.

[9]  S. Gilboa,et al.  Antidepressant Prescription Claims Among Reproductive-Aged Women With Private Employer-Sponsored Insurance - United States 2008-2013. , 2016, MMWR. Morbidity and mortality weekly report.

[10]  C. Gnoth,et al.  Development of the first urinary reproductive hormone ranges referenced to independently determined ovulation day , 2015, Clinical chemistry and laboratory medicine.

[11]  E. Garne,et al.  Selective serotonin reuptake inhibitor prescribing before, during and after pregnancy: a population‐based study in six European regions , 2015, BJOG : an international journal of obstetrics and gynaecology.

[12]  A. Hansen,et al.  Maternal use of selective serotonin reuptake inhibitors and risk of miscarriage - assessing potential biases. , 2015, Paediatric and perinatal epidemiology.

[13]  B. Stricker,et al.  Prescription and indication trends of antidepressant drugs in the Netherlands between 1996 and 2012: a dynamic population-based study , 2015, European Journal of Clinical Pharmacology.

[14]  H. Poulsen,et al.  Exposure to Selective Serotonin Reuptake Inhibitors in Early Pregnancy and the Risk of Miscarriage , 2014, Obstetrics and gynecology.

[15]  Enrique F Schisterman,et al.  A randomised trial to evaluate the effects of low-dose aspirin in gestation and reproduction: design and baseline characteristics. , 2013, Paediatric and perinatal epidemiology.

[16]  J. Olsen,et al.  Prenatal Antidepressant Exposure and Risk of Spontaneous Abortion – A Population-Based Study , 2013, PloS one.

[17]  J. West,et al.  Live and Non-Live Pregnancy Outcomes among Women with Depression and Anxiety: A Population-Based Study , 2012, PloS one.

[18]  M. Bixo,et al.  Allopregnanolone, a GABAA receptor agonist, decreases gonadotropin levels in women. A preliminary study , 2011, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[19]  A. Higgins,et al.  Antidepressant-associated sexual dysfunction: impact, effects, and treatment. , 2010, Drug, healthcare and patient safety.

[20]  A. Bérard,et al.  Use of antidepressants during pregnancy and the risk of spontaneous abortion , 2010, Canadian Medical Association Journal.

[21]  T. Einarson,et al.  Rates of spontaneous and therapeutic abortions following use of antidepressants in pregnancy: results from a large prospective database. , 2009, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[22]  D. Stewart,et al.  The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. , 2009, Obstetrics and gynecology.

[23]  J. Skurnick,et al.  Characteristics of the urinary luteinizing hormone surge in young ovulatory women. , 2007, Fertility and sterility.

[24]  S. Moenter,et al.  Neurosteroids alter gamma-aminobutyric acid postsynaptic currents in gonadotropin-releasing hormone neurons: a possible mechanism for direct steroidal control. , 2003, Endocrinology.

[25]  P. Marken,et al.  Selecting a Selective Serotonin Reuptake Inhibitor: Clinically Important Distinguishing Features. , 2000, Primary care companion to the Journal of clinical psychiatry.

[26]  C. Weinberg,et al.  Time of implantation of the conceptus and loss of pregnancy. , 1999, The New England journal of medicine.

[27]  F. Petraglia,et al.  The neuroactive steroid allopregnanolone suppresses hypothalamic gonadotropin-releasing hormone release through a mechanism mediated by the gamma-aminobutyric acidA receptor. , 1998, The Journal of endocrinology.

[28]  K. Jones,et al.  Birth outcomes in pregnant women taking fluoxetine. , 1996, New England Journal of Medicine.

[29]  G. Koren,et al.  Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac) , 1993, JAMA.